Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by TheeRookon Dec 06, 2020 1:55am
258 Views
Post# 32045463

RE:RE:RE:The truth about discordant NML results

RE:RE:RE:The truth about discordant NML results Seven AG tests now approved and more in queue.  Not a lot of excess production capacity, so takes time to build up new production.  

BinaxNOW, Abbott 50 million tests per month beginning in October. 

Quidel, which was manufacturing 2.1 million tests a week in early October, aims to ramp up production to nearly 6 million tests a week by mid-2021

BD is leveraging its global manufacturing network and scale to produce 8 million SARS-CoV-2 antigen tests per month by October and expects to produce 12 million tests per month by March 2021.


LumiraDx SARS-CoV-2 antigen test, 2 million tests in September, and will ramp to 10 million tests produced in December.


Ginkgo Bioworks announced it has secured access to at least 10 million rapid antigen test kits from Access Bio, a global in vitro diagnostics company. The tests will be available through Concentric by Ginkgo, the company's end-to-end service for COVID-19 testing, for organizations seeking to use testing as part of their broader public health strategies. Additionally, Ginkgo provided capital to expand manufacturing capacity at Access Bio's New Jersey factory for production of rapid diagnostic tests.


South Korea's Celltrion has started selling coronavirus screening kits in the U.S. to help bridge the country's testing gap, the company said Wednesday.    Imports #s  ??


 If u get the drift .   All established testing companies that manufacture their own tests.  QA is on themselves.

Pandora wrote:
"with all these better Antigen tests being apporved by the FDA"

Seems to me that was a very short list of "all these better" the last time I saw the FDA approvals on Antigen.


<< Previous
Bullboard Posts
Next >>